Lawmakers are weighing an array of pharmacy bills this session that could rein in prescription prices and allow pharmacists to treat people for COVID-19

The price cuts would target medication used to treat diabetes, heart failure, blood cancers, kidney disease and other ailments.

Republican Siobhan Dunnavant opposed creating a prescription drug affordability board to make medicine more affordable for Virginians.

The law makes New York the third state to make it possible for residents to access contraception without going to a doctor.

Florida Republican Gov. Ron DeSantis has taken more than $350,000 in campaign contributions from the pharmaceutical industry since 2019.

More than 63 million Americans who are enrolled in Medicare benefit from the agency’s new ability to cap the costs of prescription medicines.

Dealing with a chronic illness is already stressful on its own. But when you can’t afford your medication, it makes living with a chronic illness that much harder.

The Inflation Reduction Act will save the program money by allowing negotiation with drug companies for lower prescription costs.

‘It’s not a legitimate role of government to be involved in health care in any way,’ said New Hampshire GOP Senate candidate Bruce Fenton.

Every Republican in Congress opposed the law despite its widespread popularity.

Incumbent Rep. Angie Craig (D-MN) is running against Republican nominee Tyler Kistner, who accused Democrats in Congress of working to implement ‘a communist-centered-type health care plan.’

The Democratic proposal would cap drug prices and allow the government to negotiate Medicare drug prices.

Nevada Republican Senate candidate Adam Laxalt and his spouse appear to have increased their holdings in a major pharmaceutical company since December.

A new poll shows strong support for a compromise Build Back Better package.

Pennsylvania GOP Senate candidate Mehmet Oz has presented himself as a champion against high drug prices.

Nevada Republican Adam Laxalt and his wife own more than $67,000 in pharmaceutical stocks, according to his recent financial disclosure statement.

The American Action Network received $4.5 million from the U.S. pharmaceutical industry’s largest interest group in 2019. Now, the group is airing misleading claims about Democrats’ plans to make prescription drugs more affordable.

Every House Republican voted against President Joe Biden’s sweeping social safety net plan.

A new analysis shows H.R. 3 would bring the cost of common medications down significantly.

The American Action Network has received millions of dollars from the pharmaceutical industry.

‘We ran out of time,’ an official with the Trump administration said.

Donald Trump makes his final appeals to voters as the presidential campaign nears its end.

The steps the administration has taken have been less ambitious than those in a bill the House passed last year.

Senate Majority Leader Mitch McConnell is still refusing to hold a vote on bipartisan bills to address rising drug costs.

New legislation was introduced days before the White House files arguments with the Supreme Court to get rid of the Affordable Care Act.

The bipartisan, House-passed H.R. 3 would lower drug costs for all Americans.

The high cost of prescription drugs is one of the top concerns among voters.

Polling shows that drug prices and health care affordability are the top issues for Americans. Mitch McConnell is blocking legislation to address both.

Senate Majority Leader Mitch McConnell said in September that he would not allow a vote on the Lower Drug Costs Now Act.

Zero Democrats have cosponsored the legislation.